Piedmont Heart Institute Napa Valley Cardiology Conference
Playback speed
10 seconds
Treating the Tricuspid Valve Patient of the Future
26 views
November 3, 2017
When a tricuspid regurgitation patient is referred for tricuspid valve treatment, they are typically at ...
read more ↘ the end of their disease process. We need a paradigm shift to treating patients earlier, agreed Dr. Chris Meduri from Piedmont Heart, Dr. Paul Sorajja from Minneapolis Heart Institute and Dr. Gorav Ailawadi from the University of Virginia. The Napa Valley Cardiology Conference presenters discuss the future of the nascent tricuspid space and how to tackle the challenges.
↖ read less
read more ↘ the end of their disease process. We need a paradigm shift to treating patients earlier, agreed Dr. Chris Meduri from Piedmont Heart, Dr. Paul Sorajja from Minneapolis Heart Institute and Dr. Gorav Ailawadi from the University of Virginia. The Napa Valley Cardiology Conference presenters discuss the future of the nascent tricuspid space and how to tackle the challenges.
↖ read less
Comments 0
Login to view comments.
Click here to Login
2017 Conference